Analysts at JMP Securities raised their rating on shares of Intercept Pharma (ICPT [1]) from "Market Perform" to "Market Outperform" on Wednesday.
[1] https://www.investorsobserver.com/symbols/ICPT/
InvestorsKeyhole Trade Alert
IK-> The technicals for ICPT ($114.19 up $1.85) are bullish with an upwards trend. Support has been around $108.00. Look at the Apr 70/75 bull-put spread for a 50-cent credit or better. That’s good for a 11.1% return and the stock has to fall 34.3% to cause a problem. [Various news and data; InvestorsKeyhole]
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
%20is%20a%20Top%20Growth%20Stock%20for%20the%20Long-Term%20%7C%20Nasdaq&_biz_n=0&rnd=438621&cdn_o=a&_biz_z=1742180718943)
%20stock%20upgraded%20to%20Market%20Outperform%20%7C%20Nasdaq&_biz_n=1&rnd=294805&cdn_o=a&_biz_z=1742180718944)
%20stock%20upgraded%20to%20Market%20Outperform%20%7C%20Nasdaq&rnd=263865&cdn_o=a&_biz_z=1742180718947)